Skip to main content
. Author manuscript; available in PMC: 2018 May 16.
Published in final edited form as: Leukemia. 2017 Nov 16;32(4):986–995. doi: 10.1038/leu.2017.331

Table 5.

a. Post-relapse survival based on timing of relapse (early vs. late)
Relapse within 24 months (N = 1156) Relapse after 24 months (N=984)
Outcomes Number Probability (95% CI) Number Probability (95% CI) p-value
Post relapse survival 1155 984 <0.001
1-year 65 (63–68)% 80 (77–82)%
2-year 50 (47–53)% 66 (62–69)%
3-year 38 (35–41)% 53 (49–56)%
4-year 30 (27–33)% 41 (38–45)%
b. Post-relapse survival trend of early relapse within 24 months during transplant year from 2001–2013
2001–2004
(N = 342)
2005–2008
(N = 535)
2009–2013
(N = 336)

Outcomes Number Probability (95% CI) Number Probability (95% CI) Number Probability (95% CI) p-value
Overall Survival 342 535 336 0.006
1-year 58 (53–64)% 70 (66–74)% 68 (63–73)%
2-year 42 (37–47)% 54 (50–59)% 53 (47–59)%
3-year 32 (27–37)% 42 (37–46)% 41 (35–47)%
5-year 22 (17–27)% 25 (21–29)% 23 (16–31)%
c. Post-relapse survival of early relapse within 24 months by relapse year before and after 2005
Relapsed before 2005
(N = 284)
Relapsed in or after 2005
(N = 929)

Outcomes Number Probability (95% CI) Number Probability (95% CI) p-value
Post relapse Survival 284 929 0.005
1-year 59 (53–64)% 69 (66–72)%
2-year 42 (36–48)% 53 (50–57)%
3-year 30 (25–36)% 41 (38–45)%
4-year 23 (18–29)% 33 (29–36)%
5-year 22 (17–27)% 25 (21–28)%